Company Search:
Advanced Search
Sponsored Links
Granules India Limited Company Snapshot
Granules India Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Granules India Limited with three other companies in this sector in India: Dishman Carbogen Amcis Ltd (2018 sales of 16.95 billion Indian Rupees [US$240.32 million] of which 75% was CRAMS.), Nectar Lifesciences Limited (18.74 billion Indian Rupees [US$265.74 million] of which 100% was Bulk drugs), and Pfizer Limited (19.69 billion Indian Rupees [US$279.13 million] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended March of 2018, sales at Granules India Limited were 16.85 billion Indian Rupees (US$238.88 million). This is an increase of 19.4% versus 2017, when the company's sales were 14.11 billion Indian Rupees.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Granules India Limited
  Stock Performance Chart for Granules India Limited
  Stock Data: Recent Stock Performance:
  Current Price (2/8/2019): 86.65
(Figures in Indian Rupees)
1 Week -2.9%   13 Weeks -3.8%  
4 Weeks -17.7%   52 Weeks -27.0%  
Granules India Limited Key Data:
  Ticker: GRANULES Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 16,846,223,000
(Year Ending Jan 2019).
Employees: 4,133
  Currency: Indian Rupees Market Cap: 22,030,551,247
  Fiscal Yr Ends: March Shares Outstanding: 254,247,562
  Share Type: Ordinary Closely Held Shares: 118,752,439
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.